Lusine Aghajanova1, Sahar Houshdaran2, Shaina Balayan2, Evelina Manvelyan2, Juan C Irwin2, Heather G Huddleston2, Linda C Giudice2. 1. Department of Obstetrics, Gynecology and Reproductive Sciences, Center for Reproductive Sciences, and Center for Reproductive Health, University of California San Francisco, 550 16th Street, 7th Floor, Box 0132, San Francisco, CA, 94158, USA. lusine.aghajanova@ucsf.edu. 2. Department of Obstetrics, Gynecology and Reproductive Sciences, Center for Reproductive Sciences, and Center for Reproductive Health, University of California San Francisco, 550 16th Street, 7th Floor, Box 0132, San Francisco, CA, 94158, USA.
Abstract
PURPOSE: The study aims to test the hypothesis that platelet-rich plasma (PRP) stimulates cellular processes involved in endometrial regeneration relevant to clinical management of poor endometrial growth or intrauterine scarring. METHODS: Human endometrial stromal fibroblasts (eSF), endometrial mesenchymal stem cells (eMSC), bone marrow-derived mesenchymal stem cells (BM-MSC), and Ishikawa endometrial adenocarcinoma cells (IC) were cultured with/without 5% activated (a) PRP, non-activated (na) PRP, aPPP (platelet-poor-plasma), and naPPP. Treatment effects were evaluated with cell proliferation (WST-1), wound healing, and chemotaxis Transwell migration assays. Mesenchymal-to-epithelial transition (MET) was evaluated by cytokeratin and vimentin expression. Differential gene expression of various markers was analyzed by multiplex Q-PCR. RESULTS: Activated PRP enhanced migration of all cell types, compared to naPRP, aPPP, naPPP, and vehicle controls, in a time-dependent manner (p < 0.05). The WST-1 assay showed increased stromal and mesenchymal cell proliferation by aPRP vs. naPRP, aPPP, and naPPP (p < 0.05), while IC proliferation was enhanced by aPRP and aPPP (p < 0.05). There was no evidence of MET. Expressions of MMP1, MMP3, MMP7, and MMP26 were increased by aPRP (p < 0.05) in eMSC and eSF. Transcripts for inflammation markers/chemokines were upregulated by aPRP vs. aPPP (p < 0.05) in eMSC and eSF. No difference in estrogen or progesterone receptor mRNAs was observed. CONCLUSIONS: This is the first study evaluating the effect of PRP on different human endometrial cells involved in tissue regeneration. These data provide an initial ex vivo proof of principle for autologous PRP to promote endometrial regeneration in clinical situations with compromised endometrial growth and scarring.
PURPOSE: The study aims to test the hypothesis that platelet-rich plasma (PRP) stimulates cellular processes involved in endometrial regeneration relevant to clinical management of poor endometrial growth or intrauterine scarring. METHODS:Human endometrial stromal fibroblasts (eSF), endometrial mesenchymal stem cells (eMSC), bone marrow-derived mesenchymal stem cells (BM-MSC), and Ishikawa endometrial adenocarcinoma cells (IC) were cultured with/without 5% activated (a) PRP, non-activated (na) PRP, aPPP (platelet-poor-plasma), and naPPP. Treatment effects were evaluated with cell proliferation (WST-1), wound healing, and chemotaxis Transwell migration assays. Mesenchymal-to-epithelial transition (MET) was evaluated by cytokeratin and vimentin expression. Differential gene expression of various markers was analyzed by multiplex Q-PCR. RESULTS: Activated PRP enhanced migration of all cell types, compared to naPRP, aPPP, naPPP, and vehicle controls, in a time-dependent manner (p < 0.05). The WST-1 assay showed increased stromal and mesenchymal cell proliferation by aPRP vs. naPRP, aPPP, and naPPP (p < 0.05), while IC proliferation was enhanced by aPRP and aPPP (p < 0.05). There was no evidence of MET. Expressions of MMP1, MMP3, MMP7, and MMP26 were increased by aPRP (p < 0.05) in eMSC and eSF. Transcripts for inflammation markers/chemokines were upregulated by aPRP vs. aPPP (p < 0.05) in eMSC and eSF. No difference in estrogen or progesterone receptor mRNAs was observed. CONCLUSIONS: This is the first study evaluating the effect of PRP on different human endometrial cells involved in tissue regeneration. These data provide an initial ex vivo proof of principle for autologous PRP to promote endometrial regeneration in clinical situations with compromised endometrial growth and scarring.
Authors: Joseph C Chen; Jacquelyn R Hoffman; Ripla Arora; Lila A Perrone; Christian J Gonzalez-Gomez; Kim Chi Vo; Diana J Laird; Juan C Irwin; Linda C Giudice Journal: Fertil Steril Date: 2015-10-26 Impact factor: 7.329
Authors: Inmaculada Moreno; Francisco M Codoñer; Felipe Vilella; Diana Valbuena; Juan F Martinez-Blanch; Jorge Jimenez-Almazán; Roberto Alonso; Pilar Alamá; Jose Remohí; Antonio Pellicer; Daniel Ramon; Carlos Simon Journal: Am J Obstet Gynecol Date: 2016-10-04 Impact factor: 8.661
Authors: Chris Hyunchul Jo; Ji Sun Shin; Young Gil Lee; Won Hyoung Shin; Hyang Kim; Seung Yeon Lee; Kang Sup Yoon; Sue Shin Journal: Am J Sports Med Date: 2013-08-06 Impact factor: 6.202
Authors: Maya N Mascarenhas; Seth R Flaxman; Ties Boerma; Sheryl Vanderpoel; Gretchen A Stevens Journal: PLoS Med Date: 2012-12-18 Impact factor: 11.069
Authors: Min Kyoung Kim; Jung Ah Yoon; Sook Young Yoon; Mira Park; Woo Sik Lee; Sang Woo Lyu; Haengseok Song Journal: Cells Date: 2022-05-05 Impact factor: 7.666
Authors: Fady I Sharara; Latashia-Lika Lelea; Sara Rahman; Jordan S Klebanoff; Gaby N Moawad Journal: J Assist Reprod Genet Date: 2021-03-15 Impact factor: 3.412
Authors: Lorenzo G T M Segabinazzi; Igor F Canisso; Giorgia Podico; Lais L Cunha; Guilherme Novello; Michael F Rosser; Shavahn C Loux; Fabio S Lima; Marco A Alvarenga Journal: Antibiotics (Basel) Date: 2021-04-23